ST11-KL64 bla-KPC-2 NTCC?肺炎克雷伯氏菌多藥耐藥株Klebsiella pneumoniae BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心
- 價 格：￥989850
- 貨 號：NTCC?ST11-KL64 bla-KPC-2
- 產 地：北京
- BioVector NTCC典型培養物保藏中心
- 聯系人：Dr.Xu, Biovector NTCC Inc.
電話：400-800-2947 工作QQ:1843439339 (微信同號)
郵件：Biovector@163.com
手機：18901268599
地址：北京
- 已注冊
ST11-KL64 bla-KPC-2 NTCC?肺炎克雷伯氏菌多藥耐藥株Klebsiella pneumoniae
BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心
ST11-KL64 bla-KPC-2 refers to a specific type of Klebsiella pneumoniae bacterium that is resistant to multiple antibiotics, including carbapenems.
Here's a breakdown:
ST11: This refers to the sequence type of the bacteria. It is determined by analyzing specific genes within the bacterial genome. ST11 is a globally disseminated and particularly concerning sequence type of K. pneumoniae due to its high resistance and virulence.
KL64: This refers to the capsular type of the bacteria. The capsule is a protective layer that surrounds the bacterial cell and plays a role in virulence and immune evasion.
bla-KPC-2: This gene encodes KPC-2, a type of Klebsiella pneumoniae carbapenemase. KPC-2 is an enzyme that inactivates carbapenem antibiotics, a class of drugs that are typically used to treat serious infections caused by K. pneumoniae.
Significance of ST11-KL64 bla-KPC-2:
Antibiotic Resistance: These bacteria are resistant to multiple antibiotics, including carbapenems, which are often the last-line treatment options for serious infections. This makes infections caused by ST11-KL64 bla-KPC-2 difficult to treat and can lead to severe outcomes.
Global Spread: ST11 is a globally disseminated clone, meaning it has spread widely across different countries and regions.
Public Health Threat: The emergence and spread of ST11-KL64 bla-KPC-2 strains pose a significant public health threat due to their high resistance and potential for causing severe infections.
Key Points:
ST11-KL64 bla-KPC-2 represents a serious threat due to its antibiotic resistance, virulence, and global spread.
Infections caused by these bacteria can be difficult to treat and can have serious consequences.
Continuous surveillance and the development of new treatment strategies are crucial to combat the spread of these resistant strains.
Image
生產廠家Supplier:
BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心
E-mail:BioVector@163.com
- 公告/新聞
